NDAORALTABLET
Approved
Apr 1991
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
4/8 — Partial
ZOVIRAX (acyclovir) by GSK is dna polymerase inhibitors [moa]. Approved for herpes simplex, hiv infection, herpes labialis and 1 more indications. First approved in 1991.
Drug data last refreshed 18h ago
Mechanism of Action
DNA Polymerase Inhibitors
Indications (4)
Worked on ZOVIRAX at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.